IL17A and depressive symptom measurement: In conclusion, data from experimental models, and to a lesser extent from clinical studies in depression, obesity and psoriatic disease, provide the impetus for the understanding for the complex nature of the immunopathogenesis of these manifestations, and suggest that IL-17 could be a common denominator cross-linking some of involved features at the cellular and molecular level in susceptible individuals.